Bupropion Hydrochloride
NDC 69097-072, Bupropion hydrochloride, tablet, film coated, extended release, from Cipla USA., Inc..
- Product NDC
- 69097-072
- Status
- Listed
- Labeler
- Cipla USA., Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207479
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE300 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-072-12 | 69097007212 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-072-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0abd64f7-5142-48f6-a487-3f5bdc3400deNADAC price for package 69097007212
GET /v1/drugs/nadac/69097007212
Use it
Look up 69097-072 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-072. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.